Minimal Hepatic Encephalopathy

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Minimal Hepatic Encephalopathy trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT06619106

Development of a Cognitive Tool for Rapid and Reliable Screening of Minimal Hepatic Encephalopathy: Pilot Study

The aim of this project is to evaluate the sensitivity and specificity of a cognitive test toward the presence of minimal hepatic encephalopathy (MHE). MHE is a…

France100 participantsStarted 2026-01-29

Treatment: Cognitive test

RecruitingPhase 4

NCT06538077

BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE

Rationale * Patients who recover from an episode of overt HE(OHE) are at risk of recurrent episodes of HE and persistent minimal hepatic encephalopathy, impact…

India336 participantsStarted 2025-02-01

Treatment: Oral Branched chain Amino acid, Rifaximin 550 MG

All recent trials (42 shown)

CompletedNot Applicable

NCT04807803

Evaluation of Minimal Hepatic Encephalopathy in Patients With Cirrhosis and Portal Hypertension

Minimal hepatic encephalopathy (MHE) is a subclinical cognitive impairment and represents the mildest type of hepatic encephalopathy (HE). Portal hypertension i…

France82 participantsStarted 2021-03-26

Treatment: Assessment of Minimal hepatic encephalopathy (MHE)

WithdrawnPhase 3

NCT04244877

Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility

Small Intestinal Bacterial Overgrowth (SIBO) is a common and increasingly recognized disorder in cirrhosis (30% to 73%). One of the most important predisposing…

Location not specified0Started 2021-09-15

Treatment: Rifaximin

Minimal Hepatic Encephalopathy

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Development of a Cognitive Tool for Rapid and Reliable Screening of Minimal Hepatic Encephalopathy: Pilot Study

BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE

All recent trials (42 shown)

Evaluation of Minimal Hepatic Encephalopathy in Patients With Cirrhosis and Portal Hypertension

Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Development of a Cognitive Tool for Rapid and Reliable Screening of Minimal Hepatic Encephalopathy: Pilot Study

BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE

All recent trials (42 shown)

Evaluation of Minimal Hepatic Encephalopathy in Patients With Cirrhosis and Portal Hypertension

Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility

Psychometric Hepatic Encephalopathy Score in Prediction of Minimal Hepatic Encephalopathy in Compensated Cirrhotic Patie…

Diagnosing Minimal Hepatic Encephalopathy

A Study of MHE in Patients With Liver Diseases

Effects of Direct-acting Antiviral Agents on HCV Cognitive Function, and Depression in HCV Related Cirrhosis: A Prospect…

Rifamycin in Minimal Hepatic Encephalopathy

Early Diagnosis and Timely Treatment of Cirrhotic Patients With Minimal Hepatic Encephalopathy (CHESS-NCRCID 2106)

Effect of Lactose in Patients With Chronic Liver Disease and Minimal Hepatic Encephalopathy

EYE-Mobile TRACKer IN the Diagnosis of Minimal Hepatic Encephalopathy

Prediction of Post-TIPS Hepatic Encephalopathy in Patients With Liver Cirrhosis

HEAL STUDY (Hepatic Encephalopathy and Albumin Study)

Effycacy of Rifaximin on Reverse Minimal Hepatic Encephalopathy and Elimation Small Intestinal Bacterial

High Protein Diet Versus Normal Protein Diet in Treating Patients With Minimal Hepatic Encephalopathy

Flicker App for Minimal Hepatic Encephalopathy

Efficacy and Safety of E.Coli Nissle 1917 in Patients With Mild (Stage 1-2) or Minimal Hepatic Encephalopathy

Rifaximin in Minimal Hepatic Encephalopathy

Minimal Hepatic Encephalopathy in Hereditary Hemorrhagic Telangiectasian

Role of MRI in Detection of Minimal Hepatic Encephalopathy

Transcranial Doppler Ultrasound and Minimal Hepatic Encephalopathy